• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Goldman reiterated coverage on SeaWorld Entertainment with a new price target

    7/24/23 10:10:47 AM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $SEAS alert in real time by email
    Goldman reiterated coverage of SeaWorld Entertainment with a rating of Buy and set a new price target of $66.00 from $75.00 previously
    Get the next $SEAS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SEAS

    DatePrice TargetRatingAnalyst
    12/14/2023$60.00 → $57.00Overweight → Equal-Weight
    Morgan Stanley
    11/1/2023$67.00 → $57.00Neutral
    JP Morgan
    7/24/2023$75.00 → $66.00Buy
    Goldman
    5/31/2023$75.00Buy
    Goldman
    5/25/2023Sector Weight
    KeyBanc Capital Markets
    4/20/2023$70.00Overweight
    Morgan Stanley
    7/13/2022Overweight → Sector Weight
    KeyBanc Capital Markets
    4/26/2022$92.00Buy
    Rosenblatt
    More analyst ratings

    $SEAS
    Leadership Updates

    Live Leadership Updates

    See more
    • SeaWorld Launches 60th Anniversary Celebrations and Unveils "There's So Much More to Sea"

      Guests are invited to take advantage of limited time promotions on tickets and passes to join the celebrations, which kick off on March 21 with in-park parties and continue with thrilling new rides, shows and experiences coming this summer DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., Feb. 5, 2024 /PRNewswire/ -- SeaWorld is turning 60 this year, and to celebrate, the world-class parks are throwing a party and marking the occasion throughout the year with all-new themed rides and attractions, exciting new presentations and shows, and plenty of other exclusive ticket and experience offers, plus limited-edition food and beverage items, merchandise and collectibles that will be announced in the

      2/5/24 8:00:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld to Open Exciting One-Of-A-Kind Marine Life Themed Rides and Experiences for the Whole Family in Every Park in 2024

      Become a 2024 Pass Member and be the first to experience the new attractions before they open to the public; 2024 passes on sale now DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., Sept. 28, 2023 /PRNewswire/ -- SeaWorld is thrilled to announce it will open one-of-a-kind marine life themed rides and attractions in every SeaWorld park in Spring 2024.  Guests to the award-winning parks in Orlando, San Antonio, and San Diego can look forward to epic journeys and experiences for the whole family that will leave them breathless, drenched, and utterly mesmerized.  Attractions include "Penguin Trek" at SeaWorld Orlando, an all-new family friendly coaster for guests 42-77 inches in height that will transp

      9/28/23 9:00:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Announces the Retirement of Michelle ("Chelle") Adams

      ORLANDO, Fla., July 3, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today announced that Chelle Adams, Chief Transformation Officer of SeaWorld Entertainment, Inc., intends to retire from SeaWorld in order to pursue personal opportunities effective August 4th, 2023. Ms. Adams will be available to the company over the coming months to ensure a smooth transition.  Marc Swanson, Chief Executive Officer of SeaWorld Entertainment, Inc. said, "On behalf of the entire Company, we want to thank Chelle for her contributions to the Company and wish her well." Chelle Adams said, "I appreciate the opportunity to have been part of the SeaW

      7/3/23 4:50:00 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by SeaWorld Entertainment Inc.

      SC 13G - United Parks & Resorts Inc. (0001564902) (Subject)

      2/13/24 1:09:05 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13G/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      2/14/23 10:41:02 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13D/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      11/14/22 4:02:56 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lipman Nathaniel was granted 1,687 shares (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/4/24 4:46:38 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Lipman Nathaniel

      3 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/4/24 4:42:26 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Hill Path Capital Partners Co-Investment S Lp was granted 1,902 shares (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:51:05 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    SEC Filings

    See more
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - United Parks & Resorts Inc. (0001564902) (Filer)

      2/13/24 4:16:14 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits (Amendment)

      8-K/A - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      1/29/24 6:30:11 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      1/26/24 4:15:14 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SeaWorld Entertainment downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded SeaWorld Entertainment from Overweight to Equal-Weight and set a new price target of $57.00 from $60.00 previously

      12/14/23 7:48:37 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • JP Morgan resumed coverage on SeaWorld Entertainment with a new price target

      JP Morgan resumed coverage of SeaWorld Entertainment with a rating of Neutral and set a new price target of $57.00 from $67.00 previously

      11/1/23 6:19:32 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Goldman reiterated coverage on SeaWorld Entertainment with a new price target

      Goldman reiterated coverage of SeaWorld Entertainment with a rating of Buy and set a new price target of $66.00 from $75.00 previously

      7/24/23 10:10:47 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care